Merck & Cie KG
Records under this name other than patents Merck & Cie KG holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,344,140 | 18F-LABELLED Folates Formerly held In force · High confidence | In force | High confidence | |
| US 9,315,506 | 18F-LABELLED Folates Formerly held In force · High confidence | In force | High confidence | |
| US 9,180,128 | Stable pharmaceutical compositions of 5,10-methylene tetrahydrofolate Formerly held In force · High confidence | In force | High confidence | |
| US 9,265,746 | Method for cell-specific targeting Formerly held In force · High confidence | In force | High confidence | |
| US 7,727,987 | Crystalline Forms of ( 6R)-L-ERYTHRO-TETRAHYDROBIOPTERIN Dihydrochloride Formerly held Term ended Term ended Oct 14, 2025 · High confidence | Term ended | Term ended Oct 14, 2025 | High confidence |
| US 8,318,745 | Crystalline Forms of (6R)-L-ERYTHRO-TETRAHYDROBIOPTERIN Dihydrochloride Formerly held Term ended Term ended Nov 17, 2024 · High confidence | Term ended | Term ended Nov 17, 2024 | High confidence |
| US 8,344,139 | Process for Preparing Crystalline Polymorphic Forms of (6R)-L-ERYTHRO-TETRAHYDROBIOPTERIN Dihydrochloride Formerly held Term ended Term ended Nov 17, 2024 · High confidence | Term ended | Term ended Nov 17, 2024 | High confidence |
| US 6,441,168 | Stable crystalline salts of 5-methyltetrahydrofolic acid Formerly held Term ended Term ended Jul 30, 2022 · USPTO record | Term ended | Term ended Jul 30, 2022 | USPTO record |
| US 6,858,731 | Process for the Preparation of Pure Stereoisomers of Tetrahydrofolic Acid Ester Salts and Tetrahydrofolic Acid by Fractionated Crystallisation of Tetrahydrofolic Acid Ester Salts Formerly held Term ended Term ended Jul 19, 2020 · High confidence | Term ended | Term ended Jul 19, 2020 | High confidence |
| US 7,816,525 | Process for the Preparation of Optically Pure Tetrahydropterins and Derivatives, and Specifically of Optically Pure Tetrahydrofolic Acid and Derivatives Thereof, by Stereospecific Hydrogenation Formerly held Term ended Term ended Jul 12, 2020 · High confidence | Term ended | Term ended Jul 12, 2020 | High confidence |